Human medicines European public assessment report (EPAR): Foscan, temoporfin, Date of authorisation: 24/10/2001, Revision: 18, Status: Authorised

Submitted by Anonymous (not verified) on 12 February 2026 - 12:30

Human medicines European public assessment report (EPAR): Foscan, temoporfin, Date of authorisation: 24/10/2001, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Fosavance, alendronic acid,colecalciferol, Date of authorisation: 24/08/2005, Revision: 31, Status: Authorised

Submitted by Anonymous (not verified) on 12 February 2026 - 12:22

Human medicines European public assessment report (EPAR): Fosavance, alendronic acid,colecalciferol, Date of authorisation: 24/08/2005, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Kyinsu, insulin icodec,semaglutide, Date of authorisation: 24/11/2025, Status: Authorised

Submitted by Anonymous (not verified) on 12 February 2026 - 12:16

Human medicines European public assessment report (EPAR): Kyinsu, insulin icodec,semaglutide, Date of authorisation: 24/11/2025, Status: Authorised

SPOR and XEVMPD status update webinar - Q1 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 28 January 2026, 10:00 (CET) to 28 January 2026, 12:30 (CET)

Submitted by Anonymous (not verified) on 12 February 2026 - 9:42

SPOR and XEVMPD status update webinar - Q1 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 28 January 2026, 10:00 (CET) to 28 January 2026, 12:30 (CET)

Human medicines European public assessment report (EPAR): Kapruvia, difelikefalin, Date of authorisation: 25/04/2022, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 12 February 2026 - 9:22

Human medicines European public assessment report (EPAR): Kapruvia, difelikefalin, Date of authorisation: 25/04/2022, Revision: 4, Status: Authorised

Committee for Medicinal Products for Human Use (CHMP): 21-24 July 2025, European Medicines Agency, Amsterdam, the Netherlands, from 21 July 2025 to 24 July 2025

Submitted by Anonymous (not verified) on 11 February 2026 - 16:25

Committee for Medicinal Products for Human Use (CHMP): 21-24 July 2025, European Medicines Agency, Amsterdam, the Netherlands, from 21 July 2025 to 24 July 2025

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness